Dr Reddys Laboratories (RDY) Price to Sales (2009 - 2026)

Dr Reddys Laboratories has reported Price to Sales for 18 years, with the latest figure at 14.19 in Q2 2026.

• On a quarterly basis, Price to Sales rose 12.95% year-over-year to 14.19 in Q2 2026; TTM through Jun 2026 was 3.3, a 3.37% increase from a year earlier, with the FY2026 full-year figure at 3.23, up 13.0% from the prior year.
• Price to Sales was 14.19 for Q2 2026 at Dr Reddys Laboratories, up from 14.06 in the prior quarter.
• The five-year high for Price to Sales was 14.35 in Q1 2024, with the low at 10.57 in Q3 2022.
• Average Price to Sales over 5 years is 12.79, with a median of 13.07 recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Price to Sales sank 31.59% in 2022, then climbed 26.56% in 2023.
• Over 5 years, Price to Sales stood at 11.23 in 2022, then advanced by 19.09% to 13.37 in 2023, then dropped by 0.51% to 13.3 in 2024, then fell by 10.14% to 11.96 in 2025, then increased by 18.67% to 14.19 in 2026.
• The last three Price to Sales figures came in at 14.19 (Q2 2026), 14.06 (Q1 2026), and 11.96 (Q4 2025), per Business Quant data.